Your browser doesn't support javascript.
loading
Resistance to erythropoiesis stimulating agents in patients treated with online hemodiafiltration and ultrapure low-flux hemodialysis: results from a randomized controlled trial (CONTRAST).
van der Weerd, Neelke C; Den Hoedt, Claire H; Blankestijn, Peter J; Bots, Michiel L; van den Dorpel, Marinus A; Lévesque, Renée; Mazairac, Albert H A; Nubé, Menso J; Penne, E Lars; ter Wee, Pieter M; Grooteman, Muriel P C.
Afiliación
  • van der Weerd NC; Department of Nephrology, Academic Medical Center, Amsterdam, The Netherlands; Department of Nephrology, VU Medical Center, Amsterdam, The Netherlands.
  • Den Hoedt CH; Department of Nephrology, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Internal Medicine, Maasstad Hospital, Rotterdam, The Netherlands.
  • Blankestijn PJ; Department of Nephrology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Bots ML; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
  • van den Dorpel MA; Department of Internal Medicine, Maasstad Hospital, Rotterdam, The Netherlands.
  • Lévesque R; Department of Nephrology, Centre Hospitalier de l'Université de Montréal, St-Luc Hospital, Québec, Canada.
  • Mazairac AH; Department of Nephrology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Nubé MJ; Department of Nephrology, VU Medical Center, Amsterdam, The Netherlands; Institute for Cardiovascular Research VU Medical Center (ICaR-VU), VU Medical Center, Amsterdam, The Netherlands.
  • Penne EL; Department of Nephrology, VU Medical Center, Amsterdam, The Netherlands; Department of Internal Medicine, Medical Center Alkmaar, Alkmaar, The Netherlands.
  • ter Wee PM; Department of Nephrology, VU Medical Center, Amsterdam, The Netherlands; Institute for Cardiovascular Research VU Medical Center (ICaR-VU), VU Medical Center, Amsterdam, The Netherlands.
  • Grooteman MP; Department of Nephrology, VU Medical Center, Amsterdam, The Netherlands; Institute for Cardiovascular Research VU Medical Center (ICaR-VU), VU Medical Center, Amsterdam, The Netherlands.
PLoS One ; 9(4): e94434, 2014.
Article en En | MEDLINE | ID: mdl-24743493
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a Medicamentos / Hemodiafiltración / Hematínicos Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a Medicamentos / Hemodiafiltración / Hematínicos Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2014 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos